These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 34517976)

  • 21. Depression is a major determinant of quality of life in patients with chronic systolic heart failure in general practice.
    Müller-Tasch T; Peters-Klimm F; Schellberg D; Holzapfel N; Barth A; Jünger J; Szecsenyi J; Herzog W
    J Card Fail; 2007 Dec; 13(10):818-24. PubMed ID: 18068614
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epidemiology and one-year outcomes in patients with chronic heart failure and preserved, mid-range and reduced ejection fraction: an analysis of the ESC Heart Failure Long-Term Registry.
    Chioncel O; Lainscak M; Seferovic PM; Anker SD; Crespo-Leiro MG; Harjola VP; Parissis J; Laroche C; Piepoli MF; Fonseca C; Mebazaa A; Lund L; Ambrosio GA; Coats AJ; Ferrari R; Ruschitzka F; Maggioni AP; Filippatos G
    Eur J Heart Fail; 2017 Dec; 19(12):1574-1585. PubMed ID: 28386917
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synergistic Effect of Disease Severity, Anxiety Symptoms and Elderly Age on the Quality of Life of Outpatients with Heart Failure.
    Figueiredo JHC; Oliveira GMM; Pereira BB; Figueiredo AEB; Nascimento EM; Garcia MI; Xavier SS
    Arq Bras Cardiol; 2020 Jan; 114(1):25-32. PubMed ID: 31482988
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Patient reported outcome in HFpEF: Sex-specific differences in quality of life and association with outcome.
    Faxén UL; Hage C; Donal E; Daubert JC; Linde C; Lund LH
    Int J Cardiol; 2018 Sep; 267():128-132. PubMed ID: 29957252
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of cardiac resynchronisation therapy on physical ability and quality of life in patients with chronic heart failure.
    Kloch Badełek M; Klocek M; Czarnecka D; Wojciechowska W; Wiliński J; Kawecka Jaszcz K
    Kardiol Pol; 2012; 70(6):581-8. PubMed ID: 22718376
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Additive prognostic value of subjective assessment with respect to clinical cardiological data in patients with chronic heart failure.
    Majani G; Pierobon A; Pinna GD; Giardini A; Maestri R; La Rovere MT
    Eur J Cardiovasc Prev Rehabil; 2011 Dec; 18(6):836-42. PubMed ID: 21450593
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lymphocytopenia is associated with poor NYHA functional class in chronic heart failure patients with reduced ejection fraction.
    Yücel H; Refiker Ege M; Zorlu A; Kaya H; Beton O; Güngör H; Acar G; Temizhan A; Çavuşoğlu Y; Zoghi M; Eren M; Ural D; Yılmaz MB
    Turk Kardiyol Dern Ars; 2015 Jul; 43(5):427-33. PubMed ID: 26148074
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Myocardial perfusion, function, and dyssynchrony in patients with heart failure: baseline results from the single-photon emission computed tomography imaging ancillary study of the Heart Failure and A Controlled Trial Investigating Outcomes of Exercise TraiNing (HF-ACTION) Trial.
    Atchley AE; Kitzman DW; Whellan DJ; Iskandrian AE; Ellis SJ; Pagnanelli RA; Kao A; Abdul-Nour K; O'Connor CM; Ewald G; Kraus WE; Borges-Neto S;
    Am Heart J; 2009 Oct; 158(4 Suppl):S53-63. PubMed ID: 19782789
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Assessment of quality of life using three activity questionnaires in heart failure patients after monthly, intermittent administration of levosimendan during a six-month period.
    Papadopoulou EF; Mavrogeni SI; Dritsas A; Cokkinos DV
    Hellenic J Cardiol; 2009; 50(4):269-74. PubMed ID: 19622496
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Correlates of quality of life in rural patients with heart failure.
    Nesbitt T; Doctorvaladan S; Southard JA; Singh S; Fekete A; Marie K; Moser DK; Pelter MM; Robinson S; Wilson MD; Cooper L; Dracup K
    Circ Heart Fail; 2014 Nov; 7(6):882-7. PubMed ID: 25146960
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Feasibility, safety, and mid-term efficacy of cardiac resynchronization therapy in patients with severe heart failure and ventricular conduction delay: Chulalongkorn experience.
    Sunsaneewitayakul B; Sitthisook S; Sangwatanaroj S; Prechawat S; Songmuang SB
    J Med Assoc Thai; 2007 Jul; 90(7):1458-66. PubMed ID: 17710992
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of nocturnal oxygen therapy in patients with chronic heart failure and central sleep apnea: CHF-HOT study.
    Nakao YM; Ueshima K; Yasuno S; Sasayama S
    Heart Vessels; 2016 Feb; 31(2):165-72. PubMed ID: 25348726
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Correlation of 6-min walk test with left ventricular function and quality of life in heart failure due to Chagas disease.
    Chambela MC; Mediano MFF; Ferreira RR; Japiassú AM; Waghabi MC; da Silva GMS; Saraiva RM
    Trop Med Int Health; 2017 Oct; 22(10):1314-1321. PubMed ID: 28805026
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prospective validation of stress echocardiography as an identifier of cardiac resynchronization therapy responders.
    Da Costa A; Thévenin J; Roche F; Faure E; Roméyer-Bouchard C; Messier M; Convert G; Barthélemy JC; Isaaz K
    Heart Rhythm; 2006 Apr; 3(4):406-13. PubMed ID: 16567286
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Iron deficiency in patients with heart failure with preserved ejection fraction and its association with reduced exercise capacity, muscle strength and quality of life.
    Bekfani T; Pellicori P; Morris D; Ebner N; Valentova M; Sandek A; Doehner W; Cleland JG; Lainscak M; Schulze PC; Anker SD; von Haehling S
    Clin Res Cardiol; 2019 Feb; 108(2):203-211. PubMed ID: 30051186
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The impact of B-type natriuretic peptide, New York Heart Association classification and depression on quality of life in nonhospitalized heart failure patients.
    Ancheta IB; Battie C; Cobb S; Ancheta C; Miller A; Chiong JR
    Prog Cardiovasc Nurs; 2009 Dec; 24(4):124-30. PubMed ID: 20002336
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Does home oxygen therapy (HOT) in addition to standard care reduce disease severity and improve symptoms in people with chronic heart failure? A randomised trial of home oxygen therapy for patients with chronic heart failure.
    Clark AL; Johnson M; Fairhurst C; Torgerson D; Cockayne S; Rodgers S; Griffin S; Allgar V; Jones L; Nabb S; Harvey I; Squire I; Murphy J; Greenstone M
    Health Technol Assess; 2015 Sep; 19(75):1-120. PubMed ID: 26393373
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of changes in quality of life among Turkish patients undergoing ventricular assist device implantation.
    Ozturk C; Ayik F; Oguz E; Ozturk P; Karapolat H; Balcioglu O; Yagdi T; Engin C; Ozbaran M
    Transplant Proc; 2012; 44(6):1735-7. PubMed ID: 22841258
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cardiac resynchronization therapy in patients with heart failure and moderately reduced ejection fraction: Could it trigger a super-response?
    Tawfik Ghanem M; Allam LE; Samir Ahmed R
    Indian Heart J; 2019; 71(3):229-234. PubMed ID: 31543195
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The impact of heart failure clinic in the improvement on quality of life of heart failure patients in Mexico.
    Mendez GF; Betancourt L; Galicia-Mora G
    Int J Cardiol; 2007 Feb; 115(2):242-3. PubMed ID: 16766057
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.